In the 15 years since our description of the antiphospholipid syndrome, it has become recognised as an important disease, not only in the world of lupus but in the broader areas of obstetrics, neurology and vascular disease.
Although advances have been made in the understanding of the interactions of antibodies, protein co-factors, clotting molecules, endothelium and platelets, much still needs to be learnt about management where strokes, in particular, continue to cause significant morbidity.
HughesGRV.Thrombosis, abortion, cerebral disease and lupus anticoagulant.Br Med J1983; 187: 1088–1089.
2.
HughesGRV.Connective tissue disease and the skin: the 1983 Prosser-White oration.Clin Exp Dermatol1984; 9: 535–544.
3.
GharaviAE, WilsonWA.The syndrome of thrombosis, thrombocytopenia and recurrent abortions associated with antiphospholipid antibodies: Hughes’ Syndrome.Lupus1996; 5: 343–344.
4.
VaaralaO.Atherosclerosis in SLE and Hughes’ syndrome.Lupus1997; 6: 489–490.
5.
DerueG. Fetal loss in systemic lupus: association with anticardiolipin antibodies.J Obsret Gynaecol1985; 2: 207–209.
6.
HarrisEN, ChanJKH, AshersonRA, HughesGRV.Thrombosis, recurrent fetal loss and thrombocytopenia: predictive value of the anticardiolipin test.Arch Intern Med1996; 146: 2153–2156.
7.
HughesGRV, AshersonRA.Formes atypiques du lupus crythemateux dissemine. In: CrosnierJ, Funck-BrentanoJL, BrackJF, and GrungeldJP (eds), Actualites Nephrologiques1984Flammarion Medicine:Paris.
8.
HarrisEN. Cerebral infarction in SLE. Association with anticardiolipin antibodies.Clin Exp Rheumatol1984; 2: 47–51.
9.
Mackworth-YoungCG, GharaviAE, BoeyML, HughesGRV.Portal and pulmonary hypertension in a case of SLE: possible relationships with clotting abnormality.Eur J Rheumtol Inflamm1984; 7: 72–74.
10.
AshersonRA, Mackworth-YoungCG, BoeyML, HughesGRV.Pulmonary hypertension in SLE.Br Med J1983; 287: 1024–1025.
11.
AshersonRA. Pulmonary hypertension in SLE: a report of 3 cases.J Rheumatol1986; 12: 416–418.
12.
HarrisEN. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies.Ann Rheum Dis1985; 44: 281–282.
13.
AshersonRA, HughesGRV.Antiphospholipid antibodies and chorea.J Rheumatol1987; 15: 377–379.
14.
AshersonRA, DerksenR, HarrisEN, HughesGRV.Chorea in systemic lupus and lupus-like disease: assocation with antiphospholipid antibodies.Semin Arthritis Rheum1987; 16: 253.
15.
AshersonRA. Arterial occlusion causing large bowel infarction in SLE. Reflection of clotting diathesis.Clin Rheumatol1986; 5: 102–106.
HerranzMT. Association between antiphospholipid antibodies and epilepsy in patients with SLE.Arthritis Rheum1994; 37: 568–571.
21.
KhamashtaMA. Association of antibodies against phospholipids with heart valve disease in SLE.Lancet1990; 335: 1541–1542.
22.
AshersonRA, HughesGRV.Addison's disease and primary antiphospholipid syndrome.Lancet1989; 2: 874.
23.
HarrisEN. Anticardiolipin antibodies: detection by radioimmuno assay and association with thrombosis in SLE.Lancet1983; 2: 1211–1214.
24.
HarrisEN, GharaviAE, PatelSP, HughesGRV.Evaluation of the anticardiolipin antibody test: report of a standardisation workshop held on April 4th, 1986.Clin Exp Immunol1987; 58: 215–222.
25.
GharaviAE, HarrisEN, AshersonRA, HughesGRV.Isotype distribution and phospholipid specificity in antiphospholipid syndrome.Ann Rheum Dis1987; 46: 1–6.
26.
HarrisEN, GharaviAE, HughesGRV.Anticardiolipin antibody testing: the need for standardisation.Arthritis Rheum1987; 30: 835–836.
HarrisEN, BaguleyE, AshersonRA, HughesGRV.Clinical and serological features of the antiphospholipid syndrome.Br J Rheumatol1987; 26: 19 (abstract).
29.
Mackworth-YoungCG, DavidJ, LoizouS, WalportMJ.Primary antiphospholipid syndrome: features in patients with raised anticardiolipin antibodies and in other disorders.Br J Rheumatol1987; 26: 94 (abstract).
30.
AshersonRA. The ‘primary’ antiphospholipid syndrome: major clinical and serological features.Medicine1989; 68: 366–372.
MatsuuraE. Anticardiolipin co-factor(s) and differential diagnosis of autoimmune disease.Lancet1990; 336: 177–178.
33.
GalliM. Anticardiolipin antibodies are directed not to cardiolipin but to a plasma protein co-factor.Lancet1990; 335: 1544–1547.
34.
McNeilHP, SimpsonRJ, ChestermanCN, KrilisSA.Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein 1.Proc Nat Acad Sci USA1990; 87: 4120–4124.
35.
RoubeyRAS.Auto-antibodies to phospholipid binding proteins: a new view of lupus anticoagulants and other ‘antiphospholipid’ antibodies.Blood1994; 84: 2854–2867.
36.
MooreJE, MohrCF.Biologically false positive serological test for syphillis. Type, incidence and cause.J Am Med Assoc1952; 150: 467–473.
37.
MooreJE, LutzWB.Natural history of SLE: approach to its study through chronic biologic false positive reactors.J Chronic Dis1949; 1: 297–316.
38.
LaurellAB, NilssonIM.Hypergammaglobulinaemia, circulating anticoagulant and biological false positive Wasserman reaction: a study of 2 cases.J Lab Clin Med1957; 49: 694–707.
39.
LeeSL, SaundersM.A disorder of blood coagulation in SLE.J Clin Invest1955; 34: 1814–1822.
40.
ThiagaraganP, ShapiroSS, De MarcoL.Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of lupus anticoagulant.J Clin Invest1980; 66: 397–407.
LechnerK.A new type of coagulation inhibitor.Thromb Diath Haemorrh1969; 21: 482–499.
43.
MuehJR, HerbstKD, RapaportSI.Thrombosis in patients with the lupus anticoagulant.Ann Intern Med1980; 92: 157–159.
44.
BeaumentJL.Syndrome hemorrhagique acquis de a un anticoagulant.Sang1954; 25: 1–5.
45.
NilssonIM. Intrauterine death and circulating ‘antithromboplastin’.Acta Med Scan1975; 197: 153–159.
46.
SoulierJP, BoffaMC.Avortements a repetition thromboses et anticoagulant circulant anti-thrompoplastine.Nouv Presse Med1980; 9: 859–864.
47.
CarrerasLO. Arterial thrombosis, intrauterine death and ‘lupus’ anticoagulant: detection of immunoglobulin interferring with prostacycline formation.Lancet1981; 1: 244–246.
48.
GeorgeJ, ShoenfeldY.The antiphospholipid ‘Hughes’ syndrome: a crossroads of autoimmunity and atherosclerosis.Lupus1997; 6: 559–560.